Gulliver W - Search Results

1

Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.

Lagacé F, Netchiporouk E, Turchin I, Gulliver W, Dutz J, Kirchhof MG, Popradi P, Gniadecki R, Lynde C, Litvinov IV. Lagacé F, et al. Among authors: gulliver w. Skin Therapy Lett. 2022 Sep;27(5):1-6. Skin Therapy Lett. 2022. PMID: 36469458 Free article. Review.

2

Long-term prognosis in patients with psoriasis.

Gulliver W. Gulliver W. Br J Dermatol. 2008 Aug;159 Suppl 2:2-9. doi: 10.1111/j.1365-2133.2008.08779.x. Br J Dermatol. 2008. PMID: 18700909 Review.

3

Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population.

Gulliver WP, Macdonald D, Gladney N, Alaghehbandan R, Rahman P, Adam Baker K. Gulliver WP, et al. J Cutan Med Surg. 2011 Jan-Feb;15(1):37-47. doi: 10.2310/7750.2010.10013. J Cutan Med Surg. 2011. PMID: 21291654

4

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN; Alefacept Clinical Study Group. Krueger GG, et al. J Am Acad Dermatol. 2002 Dec;47(6):821-33. doi: 10.1067/mjd.2002.127247. J Am Acad Dermatol. 2002. PMID: 12451365 Clinical Trial.

5

Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.

Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W. Menter A, et al. Among authors: gulliver w. Arch Dermatol. 2005 Jan;141(1):31-8. doi: 10.1001/archderm.141.1.31. Arch Dermatol. 2005. PMID: 15655139 Clinical Trial.

6

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, Gulliver W, Paul C, Molloy S, Barbier N, Thurston M, de Prost Y; Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group. Kapp A, et al. Among authors: gulliver w. J Allergy Clin Immunol. 2002 Aug;110(2):277-84. doi: 10.1067/mai.2002.126500. J Allergy Clin Immunol. 2002. PMID: 12170269 Clinical Trial.

7

A favourable benefit/risk ratio with efalizumab: a review of the clinical evidence.

Poulin Y, Papp KA, Carey W, Gulliver W, Gupta AK. Poulin Y, et al. Among authors: gulliver w. J Cutan Med Surg. 2006;9 Suppl 1:10-7. doi: 10.1007/s10227-006-0102-2. J Cutan Med Surg. 2006. PMID: 16633861 Review.

8

Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.

Tzellos T, van Straalen KR, Kyrgidis A, Alavi A, Goldfarb N, Gulliver W, Jemec GBE, Lowes MA, Marzano AV, Prens EP, Sayed CJ, van der Zee HH, Zouboulis CC. Tzellos T, et al. Among authors: gulliver w. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):395-401. doi: 10.1111/jdv.18632. Epub 2022 Oct 19. J Eur Acad Dermatol Venereol. 2023. PMID: 36184889 Free article.

9

Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.

Warren RB, Kleyn CE, Gulliver WP. Warren RB, et al. Among authors: gulliver wp. Br J Dermatol. 2011 May;164 Suppl 1:1-14. doi: 10.1111/j.1365-2133.2011.10280.x. Br J Dermatol. 2011. PMID: 21477010

10

Support needed to involve psoriasis patients in treatment decisions: survey of dermatologists.

Tan J, Stacey D, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Bhatti S. Tan J, et al. Among authors: gulliver w. J Cutan Med Surg. 2011 Jul-Aug;15(4):192-200. doi: 10.2310/7750.2011.10067. J Cutan Med Surg. 2011. PMID: 21781625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page